Vedolizumab serum trough concentrations and response to dose escalation in inflammatory bowel disease
Serum vedolizumab concentrations are associated with clinical response although, it is
unknown if vedolizumab concentrations predict response to dose escalation. The aim of this …
unknown if vedolizumab concentrations predict response to dose escalation. The aim of this …
Effect of vedolizumab dose intensification on serum drug concentrations and regain of response in inflammatory bowel disease patients with secondary loss of …
A Outtier, L Wauters, JF Rahier, P Bossuyt… - …, 2021 - Wiley Online Library
Abstract Background and Aims Dose intensification of vedolizumab (VDZ) for moderate‐to‐
severe ulcerative colitis (UC) and Crohn's disease (CD) may be effective in patients losing …
severe ulcerative colitis (UC) and Crohn's disease (CD) may be effective in patients losing …
Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
E Hüttemann, A Muzalyova, K Gröhl, S Nagl… - Journal of Clinical …, 2023 - mdpi.com
Background: Vedolizumab (VDZ) is a well-established and important therapeutic option in
the treatment of patients with inflammatory bowel disease (IBD). However, the significance of …
the treatment of patients with inflammatory bowel disease (IBD). However, the significance of …
Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel Disease
Background and Objectives: The subcutaneous (SC) formulation of vedolizumab has proven
to be effective for the maintenance of remission after intravenous induction. Little is known …
to be effective for the maintenance of remission after intravenous induction. Little is known …